Cognitive Therapy or Trazodone Not Effective for Insomnia in Hemodialysis
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 16, 2024 -- For patients undergoing hemodialysis with chronic insomnia, the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) or trazodone does not differ from placebo, according to a study published online Jan. 16 in the Annals of Internal Medicine.
Rajnish Mehrotra, M.D., from the University of Washington School of Medicine in Seattle, and colleagues compared the effectiveness of CBT-I, trazodone, and placebo for insomnia in a randomized, multicenter trial involving patients undergoing long-term hemodialysis conducted in 26 dialysis units. Overall, 126 patients with chronic insomnia were randomly assigned to six weeks of CBT-I, trazodone, or placebo (43, 42, and 41 patients, respectively).
The researchers found that the change in the Insomnia Severity Index (ISI) score from baseline to seven weeks was no different for CBT-I or trazodone versus placebo (−3.7, −4.2, and −3.1, respectively). From baseline to 25 weeks, there was no meaningful change observed in ISI scores: −4.8, −4.0, and −4.3 with CBT-I, trazodone, and placebo, respectively. Serious adverse events, especially serious cardiovascular events, occurred more often with trazodone (annualized cardiovascular serious adverse event incidence rates: 0.05, 0.64, and 0.21 with CBT-I, trazodone, and placebo, respectively).
"Given the high burden of insomnia in this population and high priority placed by patients for symptom relief, more trials are needed to investigate additional therapies for this condition," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Modest Gains in Life Expectancy Seen for Dialysis in Older Adults With eGFR
MONDAY, Aug. 19, 2024 -- For older adults, starting dialysis when the estimated glomerular filtration rate (eGFR) falls below 12 mL/min/1.73 m2 results in modest gains in life...
Poor Long-Term Sleep Trajectories Tied to Diabetes
TUESDAY, Aug. 13, 2024 -- Adults with suboptimal sleep duration trajectories are more likely to develop incident diabetes, according to a study published online June 27...
Short, Long Sleep Duration Tied to Microvascular Disease in Type 2 Diabetes
WEDNESDAY, Aug. 7, 2024 -- For individuals newly diagnosed with type 2 diabetes mellitus (T2DM), both short and long sleep duration are associated with microvascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.